Study of EBI-005 in Dry Eye Disease (DED)

PHASE3UnknownINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Dry Eye
Interventions
DRUG

EBI-005

EBI-005 is an intervention into one of two (2) study arms; 5 mg/mL topical administered 3 times per day

DRUG

Placebo

Placebo or Vehicle control comparator is an intervention into one of two (2) study arms; vehicle topical administered 3 times per day

Trial Locations (12)

16066

Cranberry Township

28803

Asheville

35294

Birmingham

38119

Memphis

40206

Louisville

45040

Mason

47150

New Albany

63131

St Louis

78229

San Antonio

92663

Newport Beach

06518

Hamden

01890

Winchester

Sponsors
All Listed Sponsors
lead

Eleven Biotherapeutics

INDUSTRY